Resistance and heteroresistance to colistin among clinical isolates of Acinetobacter baumannii

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)

(2019) Ana C Gales et al.   Open Forum Infectious Diseases

Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

(2019) Chih-Cheng Lai et al.   Infection and Drug Resistance

Colistin heteroresistance and the involvement of the PmrAB regulatory system in Acinetobacter baumannii

(2018) Yannick Charretier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antimicrobial susceptibility testing of colistin – evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli , Klebsiella pneumoniae , Pseudomonas aeruginosa , and Acinetobacter spp.

(2018) E. Matuschek et al.   CLINICAL MICROBIOLOGY AND INFECTION

Detection of colistin heteroresistance in Acinetobacter baumannii from blood and respiratory isolates

(2018) Pavithra Srinivas et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

High rate of colistin and fosfomycin resistance among carbapenemase-producing Enterobacteriaceae in Turkey

(2018) Serap Süzük Yıldız et al.   ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Development of New Tools to Detect Colistin-Resistance among Enterobacteriaceae Strains

(2018) Lucie Bardet et al.   Canadian Journal of Infectious Diseases & Medical Microbiology

Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and mcr -Positive Enterobacteriaceae: Comparison of Sensititre, MicroScan, Vitek 2, and Etest with Broth Microdilution

(2017) Ka Lip Chew et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emergence of the Uncommon Clone ST944/ST78 Carrying blaOXA-40-like and blaCTX-M-like Genes Among Carbapenem-Nonsusceptible Acinetobacter baumannii in Moscow, Russia

(2017) Nikolay Mayanskiy et al.   Microbial Drug Resistance

Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance

(2015) Zubair A. Qureshi et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial Heteroresistance: an Emerging Field in Need of Clarity

(2015) Omar M. El-Halfawy et al.   CLINICAL MICROBIOLOGY REVIEWS

Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria

(2014) Abiola O. Olaitan et al.   Frontiers in Microbiology

Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital*

(2013) L. Silvia Munoz-Price et al.   CRITICAL CARE MEDICINE

Acinetobacter baumannii: evolution of a global pathogen

(2013) Luísa C.S. Antunes et al.   Pathogens and Disease

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

(2012) Y. Cai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of heteroresistance to colistin in meningitis caused by Acinetobacter baumannii

(2011) Carlos Hernan Rodríguez et al.   JOURNAL OF INFECTION

Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin

(2009) Rodriguez Carlos Hernan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme

(2008) Wing Yau et al.   JOURNAL OF INFECTION

Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites

(2008) D. Gur et al.   JOURNAL OF MEDICAL MICROBIOLOGY